Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world.
Alpha-fetoprotein (AFP) is considered as a diagnostic and prognostic tumorous marker for …

AIM: To investigate the biological role of alpha fetoprotein (AFP) and its clinical significance
in carcinogenesis of hepatocellular carcinoma (HCC). METHODS: Clinical analysis of HCC …

Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …

A high level of serum alpha fetoprotein (AFP) is positively associated with human
hepatocellular carcinoma (HCC) carcinogenesis and metastasis; however, the function of …

Abstract α‐Fetoprotein (AFP) is often elevated in hepatocellular carcinoma (HCC). This
study was to elucidate the significance and related factors of AFP elevation in HCC in 781 …

Hepatocellular carcinoma (HCC) is a major leading cause of cancer-related death
worldwide. Alpha fetoprotein (AFP) is reactivated in a majority of hepatocellular carcinoma …

Alpha fetoprotein (AFP) is the most widely used diagnostic and prognostic serum biomarker
for hepatocellular carcinoma (HCC). Despite its wide clinical use, a systematic …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and has been
acknowledged as a leading cause of death among cirrhosis patients. Difficulties in early …

BACKGROUND α‐Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …

Abstract α-Fetoprotein (AFP) is a tumor-associated Ag, and its serum level is elevated in
patients with hepatocellular carcinoma (HCC). In vitro, AFP induces functional impairment of …